Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
Masson
C
C
Clinique neurologique, Hôpital Beaujon, Clichy, France.
Delalande
I
I
Deslys
J P
JP
Hénin
D
D
Fallet-Bianco
C
C
Dormont
D
D
Leys
D
D
D000328:Adult; D000595:Amino Acid Sequence; D007562:Creutzfeldt-Jakob Syndrome / Q000139:chemically induced* / Q000235:genetics; D005838:Genotype; D013006:Growth Hormone / Q000009:adverse effects* / Q000172:deficiency / Q000627:therapeutic use; D006720:Homozygote; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy; D008297:Male; D018620:PrPSc Proteins; D011328:Prions / Q000235:genetics*; D014633:Valine
D018620:PrPSc Proteins; D011328:Prions; D013006:Growth Hormone; D014633:Valine